Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)

March 14, 2023 updated by: Ashley Curtis, University of Missouri-Columbia

Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)

The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Columbia, Missouri, United States, 65201
        • University of Missouri

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 59 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 45-59 yrs of age
  • no neurological or psychiatric illness, dementia, or loss of consciousness > 5 mins
  • nongamers (i.e., report <1 hour of video/cognitive training games/week over last 2 yrs)
  • proficient in English (reading and writing)
  • computer meets technology requirements (i.e. Windows: Windows 7 or above using Internet Explorer 11 or Edge, Mozilla Firefox 41 and above, Google Chrome 48 and above; Mac OS: Mac OS X v10.8 and above using Safari 10 and above, Mozilla Firefox 42 and above, Google Chrome 48 and above; Android App: Android 6 or higher version; iOS App: iOS 10 or higher version
  • meet clinical dx criteria for Generalized Anxiety Disorder.

Exclusion Criteria:

  • unable to provide informed consent
  • unable to undergo randomization
  • Telephone Interview for Cognitive Status-modified (TICS) score <33, 2)
  • other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder-PLMD, narcolepsy, REM Sleep Behavior Disorder)
  • severe untreated psychiatric comorbidity that renders randomization unethical
  • psychotropic, anxiolytic medications or other medications(e.g., beta-blockers) that alter mood or sleep
  • uncorrected visual/auditory impairments
  • participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Training
8 week computerized cognitive training
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
Active Comparator: Trivia Training
8 week computerized trivia training
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed).
Up to 10 weeks
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., attention).
Up to 10 weeks
Objective Cognition - Computerized Cognitive Tasks
Time Frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., executive function).
Up to 10 weeks
Subjective Cognitive Self-Efficacy. -Cognitive Failures Questionnaire
Time Frame: Up to 10 weeks
A 25-item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy.
Up to 10 weeks
Coronavirus Anxiety Scale
Time Frame: Up to 10 weeks
5- item questionnaire that assess anxiety related to the Coronavirus.
Up to 10 weeks
Anxiety - State-Trait Anxiety Inventory
Time Frame: Up to 10 weeks
Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment.
Up to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Game-related experience- Sessions and duration played
Time Frame: Up to 10 weeks
During the intervention phase the cognitive training group will play games and will need to log the days and duration played.
Up to 10 weeks
Circadian Rhythm- Morningness-Eveningness Questionnaire
Time Frame: Up to 10 weeks
19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type.
Up to 10 weeks
Subjective Arousal- Global Cognitive Arousal-Perceived Stress Scale
Time Frame: Up to 10 weeks
Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a likert scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress.
Up to 10 weeks
Subjective Arousal- Pre-sleep Arousal Scale
Time Frame: Up to 10 weeks
Pre-sleep Arousal Scale is a 16-item self-report questionnaire comprising both cognitive and somatic manifestations of arousal.
Up to 10 weeks
Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale
Time Frame: Up to 10 weeks
Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal.
Up to 10 weeks
Game Engagement Questionnaire
Time Frame: Up to 10 weeks
Questionnaire assessing the experience of the game.
Up to 10 weeks
Mood-Depression-Beck Depression Inventory-II
Time Frame: Up to 10 weeks
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.
Up to 10 weeks
Alcohol Use - Alcohol Use Disorder Test
Time Frame: Baseline
10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year.
Baseline
Physical Activity - International Physical Activity Questionnaire
Time Frame: Up to 10 weeks
7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life.
Up to 10 weeks
Personality - Big Five Inventory
Time Frame: Baseline
10 question assessment measuring personality.
Baseline
COVID-19 related media exposure and risk questions
Time Frame: Up to 10 weeks
20- item questionnaire assessing the effects of news and social media on perception of COVID-19.
Up to 10 weeks
Subjective Intervention Efficacy- Internet Intervention Utility Questionnaire
Time Frame: Up to 10 weeks
16- item questionnaire about the use of the intervention.
Up to 10 weeks
Computer Proficiency- Computer Proficiency Questionnaire
Time Frame: Baseline
This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate.
Baseline
Subjective Behavioral Sleep- Insomnia Severity Index
Time Frame: Up to 10 weeks
Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research.
Up to 10 weeks
Beck Depression Inventory-2nd Edition
Time Frame: Up to 10 weeks
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.
Up to 10 weeks
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality.
Up to 10 weeks
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency
Up to 10 weeks
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure wake time after sleep onset
Up to 10 weeks
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure total sleep time
Up to 10 weeks
Subjective Behavioral Sleep - Electronic Daily Sleep Diaries
Time Frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep quality
Up to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 8, 2020

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

June 2, 2020

First Submitted That Met QC Criteria

June 4, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021943

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Cognitive Training

3
Subscribe